• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

甘草酸和多烯磷脂酰胆碱包载于脂质纳米粒中通过递送 p65 siRNA 改善急性肝损伤。

Incorporation of glycyrrhizic acid and polyene phosphatidylcholine in lipid nanoparticles ameliorates acute liver injury via delivering p65 siRNA.

机构信息

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing 100071, People's Republic of China; School of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan 250355, People's Republic of China.

State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, AMMS, Beijing 100071, People's Republic of China.

出版信息

Nanomedicine. 2023 Feb;48:102649. doi: 10.1016/j.nano.2022.102649. Epub 2022 Dec 27.

DOI:10.1016/j.nano.2022.102649
PMID:36584740
Abstract

Liver injury caused by hepatitis is the pathological basis of varied hepatic diseases with high morbidity and mortality. Although siRNA appears promising in therapeutics of hepatitis, efficient and safe delivery remains a challenge. In this study, we developed a new strategy of incorporating glycyrrhizic acid (GA) and polyene phosphatidylcholine (PPC) into lipid nanoparticles (GA/PPC-modified LNPs), which was capable of promoting cellular uptake, enhancing gene-silencing, reducing cytotoxicity and improving siRNA stability. GA/PPC-modified LNP and siRNA lipoplex targeting NF-κB, a key mediator of inflammation, mitigates acute liver injury, as assessed by liver histology, hematological and pro-inflammatory cytokine analysis. Furthermore, GA/PPC-modified LNPs reveal efficiently intracellular delivery of antisense oligonucleotides (ASOs) and mRNA inhibiting viral infection. In conclusion, GA/PPC-modified LNPs could be used as a promising delivery system for nucleic acid-based therapy.

摘要

肝炎引起的肝损伤是发病率和死亡率高的多种肝脏疾病的病理基础。尽管 siRNA 在肝炎治疗中具有广阔的应用前景,但高效、安全的递送仍然是一个挑战。在本研究中,我们开发了一种将甘草酸(GA)和多烯磷脂酰胆碱(PPC)整合到脂质纳米颗粒(GA/PPC 修饰的 LNPs)中的新策略,该策略能够促进细胞摄取、增强基因沉默、降低细胞毒性和提高 siRNA 稳定性。靶向 NF-κB(炎症的关键介质)的 GA/PPC 修饰的 LNP 和 siRNA 脂质体通过肝组织学、血液学和促炎细胞因子分析减轻急性肝损伤。此外,GA/PPC 修饰的 LNPs 可有效递送至细胞内的反义寡核苷酸(ASOs)和 mRNA,抑制病毒感染。总之,GA/PPC 修饰的 LNPs 可用作基于核酸的治疗的有前途的递送系统。

相似文献

1
Incorporation of glycyrrhizic acid and polyene phosphatidylcholine in lipid nanoparticles ameliorates acute liver injury via delivering p65 siRNA.甘草酸和多烯磷脂酰胆碱包载于脂质纳米粒中通过递送 p65 siRNA 改善急性肝损伤。
Nanomedicine. 2023 Feb;48:102649. doi: 10.1016/j.nano.2022.102649. Epub 2022 Dec 27.
2
Development of amino acid-modified biodegradable lipid nanoparticles for siRNA delivery.氨基酸修饰的可生物降解脂质纳米粒用于 siRNA 递送的研究进展。
Acta Biomater. 2022 Dec;154:374-384. doi: 10.1016/j.actbio.2022.09.065. Epub 2022 Sep 30.
3
Engineered ionizable lipid nanoparticles mediated efficient siRNA delivery to macrophages for anti-inflammatory treatment of acute liver injury.工程化可电离脂质纳米颗粒介导小干扰RNA高效递送至巨噬细胞用于急性肝损伤的抗炎治疗。
Int J Pharm. 2023 Jan 25;631:122489. doi: 10.1016/j.ijpharm.2022.122489. Epub 2022 Dec 13.
4
Chemistry of Lipid Nanoparticles for RNA Delivery.脂质纳米颗粒的 RNA 递送化学。
Acc Chem Res. 2022 Jan 4;55(1):2-12. doi: 10.1021/acs.accounts.1c00544. Epub 2021 Dec 1.
5
Lipid nanoparticle formulations for optimal RNA-based topical delivery to murine airways.用于优化基于 RNA 的经皮递送至小鼠气道的脂质纳米颗粒制剂。
Eur J Pharm Sci. 2022 Sep 1;176:106234. doi: 10.1016/j.ejps.2022.106234. Epub 2022 Jun 8.
6
Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platform.通过脂质纳米颗粒平台对小干扰RNA肝脏递送的生理和生化屏障进行定量分析。
Mol Pharm. 2014 May 5;11(5):1424-34. doi: 10.1021/mp400584h. Epub 2014 Apr 1.
7
siRNA-loaded biodegradable lipid nanoparticles ameliorate concanavalin A-induced liver injury.负载小干扰RNA的可生物降解脂质纳米颗粒可改善伴刀豆球蛋白A诱导的肝损伤。
Mol Ther Nucleic Acids. 2021 Sep 10;25:708-715. doi: 10.1016/j.omtn.2021.08.023. eCollection 2021 Sep 3.
8
Highly specific delivery of siRNA to hepatocytes circumvents endothelial cell-mediated lipid nanoparticle-associated toxicity leading to the safe and efficacious decrease in the hepatitis B virus.高特异性地将 siRNA 递送至肝细胞可避免内皮细胞介导的脂质纳米颗粒相关毒性,从而安全有效地降低乙型肝炎病毒。
J Control Release. 2017 Nov 28;266:216-225. doi: 10.1016/j.jconrel.2017.09.044. Epub 2017 Oct 3.
9
Spray drying siRNA-lipid nanoparticles for dry powder pulmonary delivery.喷雾干燥 siRNA-脂质纳米粒用于干粉肺部递药。
J Control Release. 2022 Nov;351:137-150. doi: 10.1016/j.jconrel.2022.09.021. Epub 2022 Sep 22.
10
Efficient siRNA Delivery by Lipid Nanoparticles Modified with a Nonstandard Macrocyclic Peptide for EpCAM-Targeting.非标准大环肽修饰的脂质纳米粒高效递送 siRNA 用于 EpCAM 靶向。
Mol Pharm. 2017 Oct 2;14(10):3290-3298. doi: 10.1021/acs.molpharmaceut.7b00362. Epub 2017 Aug 25.

引用本文的文献

1
Precision treatment of ventilator-induced lung injury through alveolar epithelial cell targeted lipid nanoparticle delivery.通过肺泡上皮细胞靶向脂质纳米颗粒递送实现呼吸机诱导性肺损伤的精准治疗。
Theranostics. 2025 May 25;15(13):6534-6552. doi: 10.7150/thno.111200. eCollection 2025.
2
Nucleic acid-based nanotherapeutics for treating sepsis and associated organ injuries.用于治疗脓毒症及相关器官损伤的核酸纳米疗法。
Theranostics. 2024 Jul 16;14(11):4411-4437. doi: 10.7150/thno.98487. eCollection 2024.
3
Chemical constituent characterization and determination of based on UPLC-Q-TOF-MS and HPLC combined with fingerprint and chemometric analysis.
基于超高效液相色谱-四极杆飞行时间质谱联用(UPLC-Q-TOF-MS)和高效液相色谱(HPLC)结合指纹图谱与化学计量学分析的化学成分表征与测定。
Front Plant Sci. 2024 Jun 21;15:1418480. doi: 10.3389/fpls.2024.1418480. eCollection 2024.
4
Nanotherapeutics for Alleviating Anesthesia-Associated Complications.用于缓解麻醉相关并发症的纳米治疗学。
Adv Sci (Weinh). 2024 Apr;11(15):e2308241. doi: 10.1002/advs.202308241. Epub 2024 Feb 11.
5
Lipid Nanoparticles: An Effective Tool to Improve the Bioavailability of Nutraceuticals.脂质纳米粒:提高营养保健品生物利用度的有效工具。
Int J Mol Sci. 2023 Oct 30;24(21):15764. doi: 10.3390/ijms242115764.
6
Emergence of Small Interfering RNA-Based Gene Drugs for Various Diseases.用于多种疾病的基于小干扰RNA的基因药物的出现。
ACS Omega. 2023 Jun 1;8(23):20234-20250. doi: 10.1021/acsomega.3c01703. eCollection 2023 Jun 13.
7
Safe and Effective Delivery of mRNA Using Modified PEI-Based Lipopolymers.使用基于改性聚乙烯亚胺的脂质聚合物安全有效地递送信使核糖核酸
Pharmaceutics. 2023 Jan 26;15(2):410. doi: 10.3390/pharmaceutics15020410.